Tempus AI Q2 2024 Earnings Report $68.09 -8.63 (-11.25%) As of 02/21/2025 04:00 PM Eastern Earnings HistoryForecast Tempus AI EPS ResultsActual EPS-$6.77Consensus EPS -$4.41Beat/MissMissed by -$2.36One Year Ago EPSN/ATempus AI Revenue ResultsActual Revenue$165.97 millionExpected Revenue$159.10 millionBeat/MissBeat by +$6.87 millionYoY Revenue GrowthN/ATempus AI Announcement DetailsQuarterQ2 2024Date8/6/2024TimeN/ATEM Upcoming EarningsTempus AI will be holding an earnings conference call on Monday, February 24 at 4:30 PM Eastern. Interested parties can register for or listen to the call. Conference Call ResourcesTEM Earnings History Tempus AI Earnings HeadlinesTempus AI: The AI Powerhouse That’s Revolutionizing HealthcareFebruary 22 at 2:12 AM | talkmarkets.comTempus AI, Inc. (TEM) Secures $300 Million to Fuel Ambry Genetics AcquisitionFebruary 22 at 2:12 AM | insidermonkey.comGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which is why I'm recommending ONE coin to all investors right now. February 22, 2025 | Crypto 101 Media (Ad)Tempus AI, Inc. (NASDAQ:TEM) Receives $58.55 Average Target Price from AnalystsFebruary 22 at 1:11 AM | americanbankingnews.comTempus AI, Stemline collaborate to leverage Next to help cliniciansFebruary 21 at 12:54 PM | markets.businessinsider.comWhy Tempus AI, Inc. (TEM) Crashed on ThursdayFebruary 21 at 12:54 PM | msn.comSee More Tempus AI Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Tempus AI? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tempus AI and other key companies, straight to your email. Email Address About Tempus AITempus AI (NASDAQ:TEM) Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.View Tempus AI ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles The Trade Desk Crashes on Earnings, But Growth Catalysts PersistHims & Hers Earnings Could Be a Game Changer—What to Do NowAnalysts See Buying Opportunity in NVIDIA Before EarningsAirbnb's Earnings: Sky High Results, Grounded Guidance?Is Coinbase Stock a Buy After Earnings?CVS Health: Earnings Beat Ignites Stock RallyQualcomm’s Post-Earnings Dip: A Prime Buying Opportunity? Upcoming Earnings Workday (2/24/2025)Intuit (2/25/2025)American Tower (2/25/2025)Bank of Montreal (2/25/2025)Bank of Nova Scotia (2/25/2025)Public Storage (2/25/2025)NVIDIA (2/26/2025)Synopsys (2/26/2025)Salesforce (2/26/2025)Lowe's Companies (2/26/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
